NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









SiPhox Health

SiPhox Health

Private
Burlington, MassachusettsHealthcare & Life Scienceshttps://siphoxhealth.com/

Last Round

Grant

Apr 23, 2025

Total Funding Raised

$10.74M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

SiPhox Health is a biotechnology company that develops a silicon photonics-based biosensing platform for at-home, lab-grade blood biomarker testing.

Sector

Healthcare & Life Sciences

Verticals

Telemedicine, Healthcare Analytics, D2C Brands, Semiconductors, Medical Devices

Business Model

B2C

Customer Profile

Hardware Sales, Subscription SaaS, Hardware + Subscription

AI Layer

Application

Keywords

at-home blood testingblood test kitbiomarker monitoringdirect-to-consumer testingwhite-label lab testingdigital health dashboardpreventive healthquantified selfbiohackinglab testing APIcorporate wellness testingAI health insightswearable data integrationsilicon photonicshormone testingmetabolic health

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

SiPhox Health Comps

Public and private peers based on sector, stage, and business model.

SiPhox Health comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

SiPhox Health Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantApr 23, 2025
Series A ExtensionMar 4, 2025
SeedJul 19, 2023
GrantJul 13, 2022

Key People

Founding team and executive leadership

Diedrik Vermeulen

Co-founder And CEO

Founding Team

Michael Dubrovsky

Co-Founder And CEO

Founding Team

Anthony Dias

Chief Financial Officer

Executive Team

Arman Zand

Chief Financial Officer

Executive Team

SiPhox Health Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 27, 2026

    Grew 22% QoQ, from 60 to 73 employees.

  • Apr 27, 2026

    Grew 19% quarter-over-quarter, from 57 to 68 employees.

SiPhox Health Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

SiPhox Health Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about SiPhox Health's valuation, stock price, and market status.

Firmographic Details

HeadquartersBurlington, Massachusetts
Employee Range73
Year Founded2020
Last FundingApr 23, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.